Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma: A Prospective Analysis of the Phase III GALLIUM Study. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2024)